Skip to main content
Fig. 5 | BMC Microbiology

Fig. 5

From: Characterization of novel bacteriophage PSKP16 and its therapeutic potential against β-lactamase and biofilm producer strain of K2-Hypervirulent Klebsiella pneumoniae pneumonia infection in mice model

Fig. 5

A Comparison the therapeutic and preventive effect of PSKP16 phage in bodyweight in a mice nasal infection model in 72 h post challenge. B Comparison of survival rate in 7 consecutive days post challenge. Survival rates of different groups of mice were determined. Each group contained 12 mice. Statistical analysis was performed using the Kaplan–Meier method [P < 0.0001, log-rank (Mantel-Cox) test]

Back to article page